PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+9.94%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$2.88B
AUM Growth
+$2.88B
(+9.8%)
Cap. Flow
+$39.8M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
59.16%
Holding
157
New
25
Increased
41
Reduced
52
Closed
11
Top Buys
| 1 |
TransUnion
TRU
|
$122M |
| 2 |
NXP Semiconductors
NXPI
|
$60.4M |
| 3 |
Carlisle Companies
CSL
|
$55.7M |
| 4 |
Valaris
VAL
|
$51M |
| 5 |
Intercontinental Exchange
ICE
|
$49M |
Top Sells
| 1 |
Booking.com
BKNG
|
$105M |
| 2 |
Ciena
CIEN
|
$61.5M |
| 3 |
The Mosaic Company
MOS
|
$57.5M |
| 4 |
Trip.com Group
TCOM
|
$57.4M |
| 5 |
Alibaba
BABA
|
$43.7M |
Sector Composition
| 1 | Industrials | 20.54% |
| 2 | Technology | 18.94% |
| 3 | Consumer Discretionary | 15.76% |
| 4 | Energy | 13.12% |
| 5 | Financials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Moderna
MRNA
$9.37B
| $5.86M | 0.2% |
38,126
+17,626
| +86% | +$2.71M |
|
52
Biogen
BIIB
$19.4B
| $5.7M | 0.2% |
20,511
-2,633
| -11% | -$732K |
|
|
OMGA
53
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $5.57M | 0.19% |
923,291
+339,553
| +58% | +$2.05M |
|
54
Immunovant
IMVT
$2.56B
| $5.38M | 0.19% |
346,970
-64,327
| -16% | -$998K |
|
55
Yum China
YUMC
$16.4B
| $5.17M | 0.18% |
81,548
-154,581
| -65% | -$9.8M |
|
56
Cogent Biosciences
COGT
$1.69B
| $5.15M | 0.18% |
477,080
-34,310
| -7% | -$370K |
|
57
Roivant Sciences
ROIV
$8.15B
| $4.59M | 0.16% |
622,578
+66,964
| +12% | +$494K |
|
58
Zai Lab
ZLAB
$3.68B
| $4.48M | 0.16% |
134,783
-55,557
| -29% | -$1.85M |
|
59
Merus
MRUS
$4.98B
| $4.4M | 0.15% |
239,052
+47,697
| +25% | +$878K |
|
60
Roblox
RBLX
$86.4B
| $4.35M | 0.15% |
96,697
-33,103
| -26% | -$1.49M |
|
61
Arcus Biosciences
RCUS
$1.13B
| $4.24M | 0.15% |
232,612
+77,761
| +50% | +$1.42M |
|
|
INBX
62
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $4.19M | 0.15% |
222,209
+62,082
| +39% | +$1.17M |
|
63
Match Group
MTCH
$8.98B
| $4.14M | 0.14% |
107,826
-82,640
| -43% | -$3.17M |
|
64
Esperion Therapeutics
ESPR
$448M
| $4.1M | 0.14% |
2,580,575
+1,150,574
| +80% | +$1.83M |
|
|
65
Ciena
CIEN
$13.3B
| $3.77M | 0.13% |
71,693
-1,171,796
| -94% | -$61.5M |
|
66
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $3.76M | 0.13% |
549,899
| – | – |
|
67
Zymeworks
ZYME
$1.12B
| $3.67M | 0.13% |
406,327
+10,407
| +3% | +$94.1K |
|
68
Adaptive Biotechnologies
ADPT
$2.01B
| $3.23M | 0.11% |
366,230
| – | – |
|
|
SAGE
69
DELISTED
Sage Therapeutics
SAGE
| $3.19M | 0.11% |
+75,920
| New | +$3.19M |
|
|
SIX
70
DELISTED
Six Flags Entertainment Corp.
SIX
| $3.12M | 0.11% |
116,697
-99,639
| -46% | -$2.66M |
|
71
Gossamer Bio
GOSS
$562M
| $2.98M | 0.1% |
+2,363,170
| New | +$2.98M |
|
|
ALLK
72
DELISTED
Allakos
ALLK
| $2.83M | 0.1% |
635,023
+234,579
| +59% | +$1.04M |
|
73
TORM
TRMD
$2.13B
| $2.78M | 0.1% |
89,264
| – | – |
|
74
Applied Materials
AMAT
$128B
| $2.61M | 0.09% |
21,276
-368
| -2% | -$45.2K |
|
|
75
The Mosaic Company
MOS
$10.6B
| $2.6M | 0.09% |
56,622
-1,253,914
| -96% | -$57.5M |
|